[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Empatica, Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":41},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":5},"100537273",false,"NCT06275685","Forecasting Seizures Using Intelligent Wearable Technology for Health Tracking","Forecasting Seizures Using IntelliGent Wearable Technology for Health Tracking","Foresight","Inclusion Criteria:\n\n* Subjects must be diagnosed with or be at risk of epilepsy\n* Subjects or their parents or guardians must understand and consent to be in the study;\n* Subjects or their parents or guardians must be able to read and communicate in English;\n* Subjects or their parents or guardians must be willing and able to comply with study procedures and duration;\n* Subjects must have a wrist circumference suitable for wearing the EmbracePlus device.\n\nExclusion Criteria:\n\n* Subjects, or their parents or guardians for minor study participants, who do not understand the study and the risks;\n* Subjects, or their parents or guardians for minor study participants, who are either physically or cognitively incapable of performing study activities (e.g. filling in surveys and daily e-diary);\n* Subjects who would be placed at undue medical risk associated with any procedure called for in the protocol; or\n* Subjects that are Empatica employees and actively participated in the development of this protocol or development of the Seizure Wise algorithms.","ALL","6 Years",{"count":19,"type":20},3000,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this interventional study is to develop a personalized seizure risk forecast tool in people with epilepsy.\n\nThe main questions it aims to answer are:\n\n* can we develop a future seizure probabilities tool that is more accurate than chance based on the pattern and frequency of previous generalized tonic-clonic seizure (GTCS) events, as well as changes in physiological and behavioral variables.\n* does this tool improve the lives of people with epilepsy?\n\nResearchers will compare a group that does not have access to the forecast tool to a group that does and see if it is accurate and if people with it report that it improved their quality of life.",[26],"Epilepsy; Seizure",[28],"forecasting","RECRUITING","2024-09-10",{"date":32,"type":33},"2024-09-19","ACTUAL",{"date":35,"type":33},"2024-04-11",{"date":37,"type":20},"2026-06",{"name":39,"class":40},"Empatica, Inc.","INDUSTRY",""]